Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go

Helicobacter pylori is the most common cause of gastric cancer (GC), though smoking, alcohol, diet, genetics and epigenetic factors may also have a role in the occurrence of the disease. Why H. pylori cause GC in only a minority of those infected remains unknown. Although mechanisms of H. pylori‐induced carcinogenesis are not yet well understood, several genotypes of H. pylori have been associated with strain virulence and disease risk. Primary prevention of GC should be addressed by avoiding exposure to factors that increase the risk and to promote factors associated with decrease risk. Vaccines against H. pylori are an ongoing promise and not yet available. Chemoprevention through vitamin supplementation has shown no benefit. Screening and eradication of H. pylori in the general population is not advised. Given that GC is a multiple‐steps process, the identification of patients with preneoplastic lesions with high risk of progression, and periodic endoscopic surveillance of them represents the most effective way for early diagnosis of GC. However, clinical guidelines for surveillance are lacking and there are no clear criteria to classify patients into high or low risk of progressing to GC. No study has shown the potential usefulness of combining the information on the type of preneoplastic lesions, genetic and epigenetic, lifestyle and virulence bacterial factors in order to identify high risk patients who need more intensive surveillance. The integration of all this information, in a prediction model requires further research and could be the most important contribution for reducing the burden of GC.

[1]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[2]  D. Graham,et al.  Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study , 2010, Alimentary pharmacology & therapeutics.

[3]  Peihua Ni,et al.  X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. , 2011, American journal of epidemiology.

[4]  L. Na,et al.  NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis. , 2010, Archives of medical research.

[5]  Harri Vainio,et al.  Weight control and physical activity in cancer prevention: international evaluation of the evidence. , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  Ping Yang,et al.  Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis. , 2010, Archives of medical research.

[7]  Paolo Vineis,et al.  Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC) , 2003, International journal of cancer.

[8]  L. Bravo,et al.  Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[9]  Xiaolian Gao,et al.  A Comprehensive Sequence and Disease Correlation Analyses for the C-Terminal Region of CagA Protein of Helicobacter pylori , 2009, PloS one.

[10]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[11]  Xing-han Liu,et al.  Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. , 2010, Archives of medical research.

[12]  P. Correa,et al.  Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.

[13]  G. Capellá,et al.  Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain , 2011, The American Journal of Gastroenterology.

[14]  L. Iaccarino,et al.  Hormones, immune response, and pregnancy in healthy women and SLE patients. , 2010, Swiss medical weekly.

[15]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[16]  F. Bazzoli,et al.  Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer? , 2009, Annals of Internal Medicine.

[17]  A. Sigurdsson,et al.  The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.

[18]  Tai-xiang Wu,et al.  Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians. , 2009, European journal of cancer.

[19]  G. Guyatt,et al.  Citrus fruit intake and stomach cancer risk: a quantitative systematic review , 2008, Gastric Cancer.

[20]  Yusuke Nakamura,et al.  Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.

[21]  Mario Plebani,et al.  Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[22]  C. la Vecchia,et al.  A meta-analysis on alcohol drinking and gastric cancer risk. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  G. Capellá,et al.  Gastric cancer occurrence in preneoplastic lesions: A long‐term follow‐up in a high‐risk area in Spain , 2010, International journal of cancer.

[24]  C. Rubio,et al.  Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  M. Piazuelo,et al.  Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.

[26]  J. Lagergren,et al.  Oestrogen and the enigmatic male predominance of gastric cancer. , 2008, European journal of cancer.

[27]  Tai-xiang Wu,et al.  P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature , 2007, International journal of cancer.

[28]  E. El-Omar,et al.  Helicobacter pylori infection, host genetics and gastric cancer , 2009, Journal of digestive diseases.

[29]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[30]  M. Filipe,et al.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. , 1990, Gut.

[31]  Chen Li,et al.  [Meta-analysis of association of tumor necrosis factor alpha-308 gene promoter polymorphism with gastric cancer]. , 2010, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[32]  Wei Hong Wang,et al.  Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. , 2003, Journal of the National Cancer Institute.

[33]  T. Ushijima,et al.  The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae , 2009, International journal of cancer.

[34]  M. Walker,et al.  Is intestinal metaplasia of the stomach reversible? , 2003, Gut.

[35]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[36]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[37]  D. Forman,et al.  Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. , 2011, American journal of epidemiology.

[38]  Fumiaki Sato,et al.  CpG island hypermethylation in progression of esophageal and gastric cancer , 2006, Cancer.

[39]  L. Miles The new WCRF/AICR report –Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2008 .

[40]  A. Rashid,et al.  E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. , 2008, Cancer letters.

[41]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[42]  Mark T. Whary,et al.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy , 2000, Nature Medicine.

[43]  E. Kuipers,et al.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.

[44]  Jing Wang,et al.  Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis , 2010, Digestive Diseases and Sciences.

[45]  James R. Goldenring,et al.  Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.

[46]  M. Mohagheghi,et al.  A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. , 2007, Gastroenterology.

[47]  T Rokkas,et al.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[48]  Hideo Tanaka,et al.  A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. , 2011, Gastroenterology.

[49]  Hongbing Shen,et al.  Potentially functional COX‐2 −1195G>A polymorphism increases the risk of digestive system cancers: A meta‐analysis , 2010, Journal of gastroenterology and hepatology.

[50]  Lei Yao,et al.  TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis , 2010, Medical oncology.

[51]  K. Miki Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.

[52]  T. Azuma,et al.  Meta-analysis of the relationship between CagA seropositivity and gastric cancer. , 2004, Gastroenterology.

[53]  F. Clavel-Chapelon,et al.  Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. , 2006, Carcinogenesis.

[54]  Ping Yang,et al.  Glutathione S-Transferase T1 (GSTT1) Gene Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of Epidemiologic Studies , 2010, Digestive Diseases and Sciences.

[55]  M. Rugge,et al.  Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. , 2008, Gastroenterology.

[56]  P. Taylor Prevention of gastric cancer: a miss. , 2007, Journal of the National Cancer Institute.

[57]  C. V. van Duijn,et al.  CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature. , 2007, Carcinogenesis.

[58]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[59]  Tai-xiang Wu,et al.  Interleukin10 -592 Promoter Polymorphism Associated with Gastric Cancer Among Asians: A Meta-Analysis of Epidemiologic Studies , 2010, Digestive Diseases and Sciences.

[60]  S. Narod,et al.  Family history and the risk of gastric cancer , 2009, British Journal of Cancer.

[61]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[62]  T. Meyer,et al.  Inflammation, Immunity, and Vaccines for Helicobacter , 2010, Helicobacter.

[63]  T. Cover,et al.  Helicobacter pylori VacA, a paradigm for toxin multifunctionality , 2005, Nature Reviews Microbiology.

[64]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[65]  Ping Yang,et al.  ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis , 2011, Journal of Cancer Research and Clinical Oncology.

[66]  F. Mégraud,et al.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics , 2003, British Journal of Cancer.

[67]  J. Parsonnet,et al.  Helicobacter pylori and gastric adenocarcinoma. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[68]  Lei Yao,et al.  Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis , 2011, Medical oncology.

[69]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[70]  L. Dai,et al.  Association of interleukin‐1 gene polymorphisms with gastric cancer: A meta‐analysis , 2007, International journal of cancer.

[71]  K. Miyazaki,et al.  Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. , 2008, Oncology reports.

[72]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[73]  I. Samloff,et al.  Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. , 1991, Scandinavian journal of gastroenterology. Supplement.

[74]  S. Larsson,et al.  Processed meat consumption and stomach cancer risk: a meta-analysis. , 2006, Journal of the National Cancer Institute.

[75]  E. Kuipers,et al.  Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies , 2007, Helicobacter.

[76]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[77]  G. Capellá,et al.  Genetic susceptibility and gastric cancer risk , 2002, International journal of cancer.

[78]  U. Ghoshal,et al.  Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. , 2006, World journal of gastroenterology.

[79]  T. Dragani,et al.  Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .

[80]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[81]  R. Seruca,et al.  Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer , 2007, Journal of Clinical Pathology.

[82]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .